advertisement

WGA Rescources

Boldt HC 12

Showing records 1 to 12 | Display all abstracts from Boldt HC

70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Elshatory YM
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Chin EK; Almeida DR
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Gauger EH
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Velez G
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Kwon YH; Alward WL
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Xu K
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Boldt HC
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Peraire M; Corbella M
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Russell SR
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Elshatory YM
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Mahajan VB
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Kwon YH; Gehrs KM; Boldt HC; Sohn EH; Russell SR; Folk JC; Mahajan VB
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351

Issue 18-2

Change Issue


advertisement

Oculus